683 Capital Management LLC 13D and 13G filings for Eiger BioPharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:03 pm Sale |
2023-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
683 Capital Management LLC | 70,000 4.700% |
-33,833 (-32.58%) |
Filing |
| 2023-02-14 2:23 pm Sale |
2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
683 Capital Management LLC | 103,833 7.100% |
-6,167 (-5.61%) |
Filing |
| 2022-02-11 6:34 pm Purchase |
2021-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
683 Capital Management LLC | 110,000 9.700% |
20,547 (+22.97%) |
Filing |
| 2021-02-16 3:18 pm Purchase |
2020-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
683 Capital Management LLC | 89,453 8.200% |
89,453 (New Position) |
Filing |